Digging Up the Facts on TrovaGene, Inc. (TROV)

TrovaGene, Inc. (TROV) is an interesting player in the Healthcare space, with a focus on Medical Laboratories & Research. The stock has been active on the tape, currently trading at $0.36, down from yesterday’s close by -9.62%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

TrovaGene, Inc. (TROV) currently trades with a market capitalization of $15.29 Million. That value represents a market adjusting for revenues that have been growing by 38.40 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$29.12 Million over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of -$0.13 on a per share basis this quarter. Perhaps, that suggests something about why 4.69% of the outstanding share supply is held by institutional investors.

Technical Analysis

It’s important to check the technicals to get a sense of how TROV has been acting. Looking at the stock’s movement on the chart, TrovaGene, Inc. recorded a 52-week high of $2.17. It is now trading 1.81% off that level. The stock is trading $0.36 its 50-day moving average by 0%. The stock carved out a 52-week low down at $0.23.

In recent action, TrovaGene, Inc. (TROV) has made a move of +5.88% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 12.51, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange.

Previous articleTaking a Look at the Data Behind Lumber Liquidators Holdings, Inc. (LL)
Next articleAbeona Therapeutics Inc. (ABEO): What’s the Story?